Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated April 29, 2026, titled "OneSource s Partner Dr. Reddy's Laboratories receives Health Canada Approval for Generic Semaglutide Injection".
Press Release Apr 29 2026
Filed with NSE · · 2 pages · English
Release
OneSource Specialty Pharma Limited on 6ix
Earlier from OneSource Specialty Pharma
- Press Release Apr 21 2026
- Press Release Feb 11 2026
- Press Release Nov 11 2025
- Inseego and National MSP OneSource Join Forces to Tackle the Growing 5G FWA Market Opportunity
- Press Release Aug 04 2025
Later from OneSource Specialty Pharma
- Press Release May 04 2026
- Press Release May 13 2026
- Onesource Specialty Pharma Limited Press Release Jul 24 2026
- Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "OneSource Announces Strong Q2FY27 ResultsRevenue up 37% YoY and EBITDA up 53% YoY".
Follow OneSource Specialty Pharma into a list and get an email when it puts out news.
Follow OneSource Specialty Pharma